 |
 |
General Industry
|
 |
 |
 |
|
 |
|
 |
|
 |
|
 |
|
| Title |
|
Chapter 9: Pharmaceutical Pricing in Latin America |
|
| Sub title |
|
|
|
| Author |
|
- |
|
| Publication date |
|
May 2005 |
|
| ISBN |
|
|
|
| Pages |
|
13 |
|
| Price |
|
pdf £99 | print n/a |
 |
 |
Summary
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 TABLE OF CONTENTS |
 |
The World Trade Organization (WTO) and its objectives
The WTO philosophy
The WTO and Latin America
WTO viewpoint on intellectual property rights
Trade-related Aspects of Intellectual Property Rights (TRIPS)
Intellectual property and the Latin American pharmaceutical market
Limitations of TRIPS and trade disputes
Intellectual property rights in Chile
Pricing and the developing world
Access to essential medicines in Latin America
Fighting corruption to improve access to medicines in Latin America
Consumer views on pharmaceutical prices
Latin American countries seek lower prices for HIV treatments
Case study: the Campaign for Fighting Diseases criticises developing nations for inflating drug prices
The concept of compulsory licensing
The grounds for using a compulsory licence
Brazil and HIV drug pricing
The future of compulsory licensing
Case study: Brazil builds pharmaceutical manufacturing plant in Africa
|
|
|
|
General Industry
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
| No additional author information available for this product |
|
|
|
|
|
